Response to: Low level evidence supporting the choice of optimal multimodality treatment approach in patients with stage IIIA NSCLC- ain't no mountain high enough…. to keep me getting to you by Jeremic Branislav

Couñago Lorenzo, Felipe; Rodríguez de Dios, Nuria; Montemuiño, Sara; Jové Teixidó, Josep; Martín, Margarita; Calvo Crespo, Patricia; López Mata, Miriam; Thuissard Vasallo, Israel John; Sanz Rosa, David; Taboada, Begoña; Et al.

doi:0.1016/j.lungcan.2018.06.031

Inicio

Response to: Low level evidence supporting the choice of optimal multimodality treatment approach in patients with stage IIIA NSCLC- ain't no mountain high enough…. to keep me getting to you by Jeremic Branislav

Couñago Lorenzo, Felipe; Rodríguez de Dios, Nuria; Montemuiño, Sara; Jové Teixidó, Josep; Martín, Margarita; Calvo Crespo, Patricia; López Mata, Miriam; Thuissard Vasallo, Israel John; Sanz Rosa, David; Taboada, Begoña; Et al.

Use este identificador para citar o enlazar este ítem: http://hdl.handle.net/11268/7690

Fecha: 2018

Materia UNESCO: Cáncer

Tipo: article

Exportar a:

Resumen:

We wish to thank Jeremic and colleagues for commenting on our recent article [1]. As those authors observed in their comment, our study has several limitations (all of which were described in the article) related to the retrospective design. While we appreciate the feedback provided by those authors, we would like to clarify several points raised in their letter...

Mostrar el registro completo del ítem